𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification and characterization of GFAPκ, a novel glial fibrillary acidic protein isoform

✍ Scribed by Jenny Blechingberg; Ida Elisabeth Holm; Karsten Bork Nielsen; Torben Heick Jensen; Arne Lund Jørgensen; Anders Lade Nielsen


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
528 KB
Volume
55
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Glial fibrillary acidic protein (GFAP) is the principal component of the intermediary filaments in mature astrocytes of the central nervous system (CNS). The protein consists of three domains: the head, the coiled‐coil, and the tail. Here, we describe the isolation of an evolutionary conserved novel GFAP isoform, GFAPκ, produced by alternative splicing and polyadenylation of the 3′‐region of the human GFAP pre‐mRNA. As a consequence, the resulting human GFAPκ protein harbors a nonconserved C‐terminal tail sequence distinct from the tails of GFAPα, the predominant GFAP isoform, and GFAPε, an isoform which also results from alternative splicing. The head and coiled‐coil rod domains are identical between the three GFAP isoforms. Interestingly, GFAPκ is incapable of forming homomeric filaments, and increasing GFAPκ expression levels causes a collapse of intermediate filaments formed by GFAPα. In searching for a biological relevance of GFAPκ, we noticed that mRNA expression levels of GFAPα, GFAPε, and GFAPκ are gradually increased during development of the embryonic pig brain. However, whereas the GFAPα/GFAPε ratio is constant, the GFAPκ/GFAPε ratio decreases during brain development. Furthermore, in glioblastoma tumors, an increased GFAPκ/GFAPε ratio is detected. Our results suggest that the relative expression level of the GFAPκ isoform could modulate the properties of GFAP intermediate filaments and perhaps thereby influencing the motility of GFAP positive astrocytes and progenitor cells within the CNS. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


A study of glial fibrillary acidic prote
✍ H. B. Marsden; S. Kumar; J. Kahn; B. J. Anderton 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 963 KB

## Abstract A retrospective study of 366 primary brain tumours in childhood has been carried out. GFAP was detected in juvenile astrocytoma (76/121), adult astrocytoma (34/78), malignant glioma (0/8), other astrocytic tumours (2/4) and medulloblastoma (0/101). In eight medulloblastomas scanty posit

Targeting malignant gliomas with a glial
✍ Maarten ter Horst; Eric Brouwer; Suzanne Verwijnen; Mark Rodijk; Marion de Jong; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

## Abstract Glial fibrillary acidic protein (GFAP) is an intermediate filament protein abundantly expressed in malignant gliomas. We have constructed a novel oncolytic adenovirus, Ad5‐gfa2(B)3‐E1, for treatment of these tumors. In this construct, the E1 region is under control of the tissue‐specifi

Glial fiber pattern in the developing ch
✍ T. A. P. Roeling; Dr. H. K. P. Feirabend 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

The possible relation between glial fibers and the formation of longitudinal granule cell migration patterns that occur in the cerebellar anlage of the chicken was investigated by immunocytochemistry of vimentin (monoclonal antibody) and glial fibrillary acidic protein (polyclonal antibody against G

Transcriptional regulation of glial fibr
✍ H. Riol; C. Fages; M. Tardy 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

During mouse brain maturation, GFAP-mRNA undergoes a two-step developmental expression. It increases between birth and day 15 (period of astrocytic proliferation) and then decreases until day 55 (period of astrocytic morphological differentiation). We have developed an in vitro transcription procedu

Detection of the peripheral nervous syst
✍ Hélène Riol; Marcienne Tardy; Bernadette Rolland; Georges Lévesque; M.R. Ven Mur 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Glial fibrillary acidic protein (GFAP), an astroglial marker, has been detected in the peripheral nervous system (PNS) in a shorter version and its mRNA in a longer form (¬-type) than the brain a-type. To determine the characteristics of the GFAP gene expression in nonneural cells, we have investiga